By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fertility testing firm Celmatix today announced it has secured $1.5 million in additional financing to go toward the expansion of its operations and accelerate a product launch.

The round was led by Topspin Partners. Other investors including Peter Kellner of Richmond Global, Mark Gerson, founder of Gerson Lehrman Group, and Kal Vepuri, founder of the Trisiras Group, also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.